(ACST) Acasti Pharma complete technical analysis [charts+indicators] | Buy/Sell Acasti Pharma | (ACST) share price targets
Complete technical analysis of Acasti Pharma (ACST) by charts plus indicators, forecast predictions and share price targets for Acasti Pharma (ACST)
Acasti Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-28 View latest technical analysis
10 day averaged volume of Acasti Pharma is 10298
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 2.53 | 2.49 | 2.62 | 2.49 | 2.496 times |
| 27 Tue Aug 2024 | 2.48 | 2.36 | 2.50 | 2.36 | 0.804 times |
| 26 Mon Aug 2024 | 2.37 | 2.44 | 2.44 | 2.36 | 0.476 times |
| 23 Fri Aug 2024 | 2.45 | 2.44 | 2.50 | 2.40 | 0.816 times |
| 22 Thu Aug 2024 | 2.40 | 2.42 | 2.44 | 2.40 | 0.456 times |
| 21 Wed Aug 2024 | 2.46 | 2.50 | 2.50 | 2.40 | 0.486 times |
| 20 Tue Aug 2024 | 2.44 | 2.46 | 2.51 | 2.44 | 1.224 times |
| 19 Mon Aug 2024 | 2.49 | 2.41 | 2.53 | 2.41 | 1.301 times |
| 16 Fri Aug 2024 | 2.46 | 2.42 | 2.54 | 2.41 | 1.631 times |
| 15 Thu Aug 2024 | 2.50 | 2.40 | 2.52 | 2.40 | 1.068 times |
Stock of Acasti Pharma (ACST) has showed a significant upmove. This could be a good time to enter in this stock!
My analysis of stock is bullish for shortterm, and stock might move up till 2.6 or till 2.7. Use a stoploss of 2.47 and if this stock hits its stoploss, then it can fall down till 2.38
Share price targets for Acasti Pharma (ACST)
| Target Type | Value |
| Downside Target | 2.22 |
| Downside Target | 2.36 |
| Downside Target | 2.53 |
| Upside Target | 2.60 |
| Upside Target | 2.71 |
| Upside Target | 2.76 |
| Upside Target | 2.84 |
| Upside Target | 3.11 |
| Upside Target | 3.19 |
| Upside Target | 3.32 |
| Upside Target | 3.50 |
Intraday share price targets for Acasti Pharma (ACST)
| Target Type | Value |
| Downside Intraday Target | 2.39 |
| Downside Intraday Target | 2.24 |
| Upside Intraday Target | 2.65 |
| Upside Intraday Target | 2.76 |
| Downside Intraday Target | 2.5 |
Weekly technical analysis of Acasti Pharma (ACST)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 2.53 | 2.44 | 2.62 | 2.36 | 0.882 times |
| 23 Fri Aug 2024 | 2.45 | 2.41 | 2.53 | 2.40 | 0.659 times |
| 16 Fri Aug 2024 | 2.46 | 2.40 | 2.76 | 2.36 | 0.984 times |
| 09 Fri Aug 2024 | 2.36 | 2.60 | 2.71 | 2.36 | 3.295 times |
| 02 Fri Aug 2024 | 2.71 | 2.74 | 2.84 | 2.65 | 0.468 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Acasti Pharma (ACST)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Wed Aug 2024 | 2.53 | 2.71 | 2.76 | 2.36 | 1.018 times |
| 31 Wed Jul 2024 | 2.70 | 2.89 | 3.19 | 2.68 | 0.65 times |
| 28 Fri Jun 2024 | 2.92 | 2.70 | 3.32 | 2.22 | 1.065 times |
| 31 Fri May 2024 | 2.73 | 2.77 | 3.11 | 2.60 | 0.957 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Acasti Pharma (ACST)
Price action analysis of Acasti Pharma ( (ACST) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acasti Pharma ( (ACST) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Acasti Pharma ( (ACST) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Acasti Pharma ( (ACST) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Acasti Pharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Acasti Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Acasti Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Acasti Pharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Acasti Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.48 and Acasti Pharma (ACST) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Acasti Pharma (ACST) stock. Volume based technical analysis of Acasti Pharma (ACST) stock is negative.
Acasti Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Acasti Pharma ( (ACST) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Acasti Pharma ( (ACST) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Acasti Pharma ( (ACST) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Acasti Pharma ( (ACST) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Acasti Pharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Acasti Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Acasti Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Acasti Pharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Acasti Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.48 and Acasti Pharma (ACST) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Acasti Pharma (ACST) stock. Volume based technical analysis of Acasti Pharma (ACST) stock is negative.
Acasti Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.